Literature DB >> 29735498

Diffuse alveolar haemorrhage and Libman-Sacks endocarditis: a rare presentation of antiphospholipid syndrome.

Brianna Bielski1, Nikhil H Shah1, Donevan Westerveld1, Carolyn Stalvey1.   

Abstract

A 26-year-old woman with a history of idiopathic thrombocytopaenic purpura and a 1-year history of blood-streaked sputum presented after a severe episode of haemoptysis with dyspnoea. Chest imaging revealed diffuse ground glass and bronchovascular nodules. Bronchoscopy revealed bilateral diffuse alveolar haemorrhage (DAH). Sputum and bronchoalveolar lavage studies were negative for infectious aetiologies. A transthoracic echocardiogram revealed Libman-Sacks endocarditis with severe mitral regurgitation and physical examination revealed retinal artery occlusion and Osler's nodes. The patient had an increased anticardiolipin Immunoglobulin IgG and anti-B2 glycoprotein IgG, suggesting antiphospholipid syndrome (APLS). The patient was then started on high-dose methylprednisolone and had an improvement in her dyspnoea and haemoptysis. She was also started on anticoagulation as treatment for Libman-Sacks endocarditis. APLS should be considered as a possible underlying aetiology for unusual presentations of DAH with concurrent Libman-Sacks endocarditis in non-intravenous drug users with existing autoimmune disorders. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  haematology (incl blood transfusion); malignant and benign haematology; respiratory medicine; rheumatology; valvar diseases

Mesh:

Substances:

Year:  2018        PMID: 29735498      PMCID: PMC5950703          DOI: 10.1136/bcr-2017-223728

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

1.  Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study.

Authors:  R Diz-Küçükkaya; A Hacihanefioğlu; M Yenerel; M Turgut; H Keskin; M Nalçaci; M Inanç
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

2.  Echocardiographic evaluation of patients with primary antiphospholipid syndrome.

Authors:  N Espínola-Zavaleta; J Vargas-Barrón; T Colmenares-Galvis; F Cruz-Cruz; A Romero-Cárdenas; C Keirns; M C Amigo
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

3.  Non-criteria manifestations of antiphospholipid syndrome.

Authors:  D Erkan; M D Lockshin
Journal:  Lupus       Date:  2010-04       Impact factor: 2.911

Review 4.  Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis.

Authors:  Guillaume Moulis; Alexandra Audemard-Verger; Laurent Arnaud; Cécile Luxembourger; François Montastruc; Amelia Maria Gaman; Elisabet Svenungsson; Marco Ruggeri; Matthieu Mahévas; Mathieu Gerfaud-Valentin; Andres Brainsky; Marc Michel; Bertrand Godeau; Maryse Lapeyre-Mestre; Laurent Sailler
Journal:  Autoimmun Rev       Date:  2015-12-19       Impact factor: 9.754

Review 5.  Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review.

Authors:  Kevin D Deane; Sterling G West
Journal:  Semin Arthritis Rheum       Date:  2005-12       Impact factor: 5.532

6.  Practice Bulletin No. 132: Antiphospholipid syndrome.

Authors: 
Journal:  Obstet Gynecol       Date:  2012-12       Impact factor: 7.661

7.  The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus.

Authors:  Micah T McClain; Melissa R Arbuckle; Latisha D Heinlen; Gregory J Dennis; Jon Roebuck; Mark V Rubertone; John B Harley; Judith A James
Journal:  Arthritis Rheum       Date:  2004-04

8.  Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant.

Authors:  J M Pope; C L Canny; D A Bell
Journal:  Am J Med       Date:  1991-03       Impact factor: 4.965

Review 9.  Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.

Authors:  M Hojnik; J George; L Ziporen; Y Shoenfeld
Journal:  Circulation       Date:  1996-04-15       Impact factor: 29.690

10.  Antiphospholipid antibody syndrome: diffuse alveolar hemorrhage and Libman-Sacks endocarditis in the absence of prior thrombotic events.

Authors:  Nathan Hambly; Suneet Sekhon; R Andrew McIvor
Journal:  Ulster Med J       Date:  2014-01
View more
  1 in total

Review 1.  Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome.

Authors:  Sarah Abramson Stoots; Lindsay Lief; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2019-09-06       Impact factor: 4.592

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.